fda restrictions on compounding bpc-157 just got voted in favor to be added to the 503A Bulk Drug Substances list, meaning a huge step towards being able to be prescribed and compounded in the US. Thank Big news for the peptide

Big news for the peptide space., The FDA Pharmacy Compounding Advisory Committee recently voted eight to six in favor of allowing compounding pharmacies to produce BPC 157. Here is what you need to FDA advisory committee votes to add popular peptide BPC 157 to drug compounding list ABC News An FDA advisory committee voted Thursday to remove compounding restrictions on four peptides despite little evidence the products are safe or effective for medical use. In a series of 8 6 votes (with Peptides: Legal and Regulatory Risks 503A Compounding Pharmacies Must Understand Health Law Alliance FDA is reviewing seven peptides this week, BPC 157, MOTS c, and Epitalon among them. Committee meets Thursday and Friday, and the likely outcome is tighter restrictions on compounding pharmacies. Read past the headline

SKU: 72460764708 · From metron-ms.com